All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ARS PHARMACEUTICALS, INC. Last Reported: 10/31/2023 Stock Symbol: SPRY

Business Address

11682 EL CAMINO REAL, SUITE 120

SAN DIEGO , CA US 92130

Mailing Address

11682 EL CAMINO REAL, SUITE 120

SAN DIEGO , CA US 92130
Phone Number: 858-771-9307 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 9/30/2023 6/30/2023 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Cash and Cash Equivalents $60,532,000.00 $119,017,000.00 $203,224,000.00 $218,690,000.00 $254,045,000.00 $300,660,000.00 $359,689,000.00 $374,205,000.00 $386,569,000.00 -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $2,564,000.00 $2,826,000.00 $4,175,000.00 $5,154,000.00 $7,447,000.00 $4,695,000.00 $3,338,000.00 $4,141,000.00 $4,087,000.00 -- -- -- --
Total Current Assets $244,466,000.00 $255,034,000.00 $270,799,000.00 $263,129,000.00 $261,492,000.00 $305,355,000.00 $363,027,000.00 $378,346,000.00 $390,656,000.00 -- -- -- --
Property Plant and Equipement $617,000.00 $594,000.00 $15,000.00 $2,485,000.00 $2,212,000.00 $1,907,000.00 $1,984,000.00 $1,603,000.00 $1,618,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $690,000.00 $138,000.00 -- -- -- -- -- -- -- -- -- -- --
Total Assets $248,556,000.00 $258,752,000.00 $271,064,000.00 $293,999,000.00 $333,467,000.00 $352,561,000.00 $366,976,000.00 $382,199,000.00 $394,804,000.00 -- -- -- --
Accounts Payable $2,966,000.00 $1,501,000.00 $126,000.00 $2,114,000.00 $2,078,000.00 $1,720,000.00 $1,805,000.00 $4,374,000.00 $2,583,000.00 -- -- -- --
Accrued Liabilities -- -- $3,649,000.00 $8,148,000.00 $11,727,000.00 $12,537,000.00 $12,785,000.00 $5,799,000.00 $5,278,000.00 -- -- -- --
Total Current Liabilities $11,272,000.00 $10,200,000.00 $3,990,000.00 $15,208,000.00 $19,652,000.00 $20,427,000.00 $17,326,000.00 $13,650,000.00 $11,927,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-161,000.00 $-180,000.00 $-1,623,000.00 $-1,548,000.00 $-326,000.00 $-34,000.00 -- -- -- -- -- -- --
Accumulated Deficit $-124,135,000.00 $-109,269,000.00 $-248,136,000.00 $-230,272,000.00 $-186,212,000.00 $-162,752,000.00 $-140,100,000.00 $-115,600,000.00 $-96,734,000.00 -- -- -- --
Total Stockholders' Equity $237,284,000.00 $248,552,000.00 $267,074,000.00 $278,791,000.00 $313,815,000.00 $332,134,000.00 $349,650,000.00 $368,549,000.00 $382,877,000.00 $-78,249,000.00 $-70,340,000.00 $-64,003,000.00 $-58,777,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $248,556,000.00 $258,752,000.00 $271,064,000.00 $293,999,000.00 $333,467,000.00 $352,561,000.00 $366,976,000.00 $382,199,000.00 $394,804,000.00 -- -- -- --

Statement of Operations

Date 9/30/2023 6/30/2023 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $16,862,000.00 $7,308,000.00 $37,505,000.00 $29,142,000.00 $61,501,000.00 $45,630,000.00 $29,988,000.00 $12,239,000.00 -- $15,740,000.00 $5,126,000.00 $4,414,000.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $17,978,000.00 $20,613,000.00 $63,435,000.00 $44,496,000.00 $89,584,000.00 $22,681,000.00 $43,396,000.00 $18,885,000.00 -- $19,817,000.00 $11,705,000.00 $5,242,000.00 --
Loss from Operations $-57,294,000.00 $-20,603,000.00 $-63,435,000.00 $-44,496,000.00 $-89,584,000.00 $-66,077,000.00 $-43,396,000.00 $-18,885,000.00 -- $-8,112,000.00 $-11,705,000.00 $-5,242,000.00 --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.50 $-0.34 $-0.50 -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 95,576,627 94,911,268 35,457,960 -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-0.16 $-0.34 $-0.50 -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 95,576,627 94,911,268 35,457,960 -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 -- -- -- --
Common Stock Shares Outstanding 95,796,254 95,322,953 35,882,653 35,169,725 35,107,651 35,037,136 34,963,085 34,827,204 34,701,274 -- -- -- --
Common Stock Value $9,000.00 $9,000.00 $4,000.00 $4,000.00 $4,000.00 $4,000.00 $4,000.00 $3,000.00 $3,000.00 -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com